Drugs that contain Isotretinoin
1. Absorica patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7435427 | SUN PHARM INDS INC | Pharmaceutical semi-solid composition of isotretinoin |
Sep, 2021
(2 years ago) | |
| US9089534 | SUN PHARM INDS INC | Pharmaceutical semi-solid composition of isotretinoin |
Sep, 2021
(2 years ago) | |
| US8367102 | SUN PHARM INDS INC | Pharmaceutical semi-solid composition of isotretinoin |
Sep, 2021
(2 years ago) | |
| US9078925 | SUN PHARM INDS INC | Pharmaceutical semi-solid composition of isotretinoin |
Sep, 2021
(2 years ago) | |
| US8952064 | SUN PHARM INDS INC | Pharmaceutical semi-solid composition of isotretinoin |
Sep, 2021
(2 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | May 25, 2015 |
Market Authorisation Date: 25 May, 2012
Treatment: Treatment of a skin disorder
Dosage: CAPSULE;ORAL
How can I launch a generic of ABSORICA before it's drug patent expiration?
More Information on Dosage
ABSORICA family patents
2. Absorica Ld patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9750711 | SUN PHARM | Low dose oral pharmaceutical composition of isotretinoin |
May, 2035
(11 years from now) | |
| US9700535 | SUN PHARM | Oral pharmaceutical composition of isotretinoin |
Aug, 2035
(11 years from now) | |
Market Authorisation Date: 05 November, 2019
Treatment: NA
Dosage: CAPSULE;ORAL
More Information on Dosage
ABSORICA LD family patents